Predictors of marijuana relapse in the human laboratory: Robust impact of tobacco cigarette smoking status

Biological Psychiatry

Volumn 73, Issue 3, 2013, Pages 242-248

  Haney, Margaret ^a   Bedi, Gillinder ^a   Cooper, Ziva D ^a   Glass, Andrew ^a   Vosburg, Suzanne K ^a   Comer, Sandra D ^a   Foltin, Richard W ^a  

^a Columbia University ^*  (United States)

Author keywords

Cannabinoids; cannabis; self administration; tobacco; treatment; withdrawal

Indexed keywords

ADULT; ARTICLE; CANNABIS SMOKING; DISEASE SEVERITY; FEMALE; HUMAN; INTOXICATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; SLEEP DISORDER; SMOKING; SMOKING CESSATION; WITHDRAWAL SYNDROME;

ADULT; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MARIJUANA SMOKING; RECURRENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84872675460     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2012.07.028     Document Type: Article

References (62)

1. United Nations Office on Drugs and Crime World Drug Report 2010 (United Nations Publication, Sales No. E.10.XI.13) 2010 United Nations Office on Drugs and Crime Vienna, Austria
2. Data Spotlight: Nearly 40 Percent of Substance Abuse Treatment Admissions Report Alcohol-Drug Combinations http://www.oas.samhsa.gov
3. W. Hall The mental health risks of adolescent cannabis use PLoS Medicine 3 2006 159 162
4. A. Bhana, C.D. Parry, B. Myers, A. Pluddemann, N.K. Morojele, and A.J. Flisher The South African Community Epidemiology Network on Drug Use (SACENDU) project, phases 1-8-cannabis and Mandrax S Afr Med J 92 2002 542 547
5. EMCDDA Annual Report on the State of the Drugs Problem 2009 European Monitoring Centre for Drugs and Drug Addiction Lisbon
6. SAMHSA (Substance Abuse and Mental Health Services Administration, Office of Applied Studies) Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-41, HHS Publication No. (SMA) 11-4658 2011 SAMHSA Rockville, MD
7. F.S. Stinson, W.J. Ruan, R. Pickering, and B.F. Grant Cannabis use disorders in the USA: Prevalence, correlates and co-morbidity Psychol Med 36 2006 1447 1460
8. R.S. Stephens, R.A. Roffman, and L. Curtin Extended versus brief treatment for marijuana use J Consult Clin Psychol 68 2000 898 908
9. J. Copeland, W. Swift, R. Roffman, and R. Stephens A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder J Subst Abuse Treat 21 2001 55 64
10. MTPRG Brief treatments for cannabis dependence: Findings from a randomized multisite trial J Consult Clin Psychol 72 2004 455 466
11. A.J. Budney, B.A. Moore, H.L. Rocha, and S.T. Higgins Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence J Consult Clin Psychol 74 2006 307 316
12. R.M. Kadden, M.D. Litt, E. Kabela-Cormier, and N.M. Petry Abstinence rates following behavioral treatments for marijuana dependence Addict Behav 32 2007 1220 1236
13. F.R. Levin, J.J. Mariani, D.J. Brooks, M. Pavlicova, W. Cheng, and E. Nunes Dronabinol for the treatment of cannabis dependence: A randomized, double-blind, placebo-controlled trial Drug Alcohol Depend 116 2011 142 150
14. M. Haney, A.S. Ward, S.D. Comer, R.W. Foltin, and M.W. Fischman Abstinence symptoms following smoked marijuana in humans Psychopharmacol 141 1999 395 404
15. M. Haney, C.L. Hart, A.S. Ward, and R.W. Foltin Nefazodone decreases anxiety during marijuana withdrawal in humans Psychopharmacol 165 2003 157 165
16. M. Haney, C.L. Hart, S.K. Vosburg, J. Nasser, A. Bennett, C. Zubaran, and R.W. Foltin Marijuana withdrawal in humans: Effects of oral THC or divalproex Neuropsychopharmacol 29 2004 158 170
17. M. Haney, C.L. Hart, S.K. Vosburg, S.D. Comer, S.C. Reed, and Z.D. Cooper Effects of baclofen and mirtazapine on laboratory model of marijuana withdrawal and relapse Psychopharmacology 211 2010 233 244
18. C. Hart, A.S. Ward, M. Haney, S.D. Comer, R.W. Foltin, and M.W. Fischman Comparison of smoked marijuana and oral delta(9)-tetrahydrocannabinol in humans Psychopharmacol 164 2002 407 415
19. T. Schierenbeck, D. Riemann, M. Berger, and M. Hornyak Effect of illicit recreational drugs upon sleep: Cocaine, ecstasy, and marijuana Sleep Med Rev 12 2008 381 389
20. A.J. Budney, R.G. Vandrey, J.R. Hughes, B.A. Moore, and B. Bahrenburg Oral delta-9 tetrahydrocannabinol suppresses cannabis withdrawal symptoms Drug Alcohol Depend 86 2007 22 29
21. M. Haney Self-administration of cocaine, cannabis and heroin in the human laboratory: Benefits and pitfalls Addict Biol 14 2009 9 21
22. M. Haney, C.L. Hart, S.K. Vosburg, S.D. Comer, S.C. Reed, and R.W. Foltin Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse Psychopharmacol 197 2008 157 168
23. Z.D. Cooper, R.W. Foltin, C.L. Hart, S.K. Vosburg, S.D. Comer, and M. Haney A controlled human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers [published online ahead of print June 28] Addiction Biology 2012
24. M. Haney, and R. Spealman Controversies in translational research: Drug self-administration Psychopharmacol 199 2008 403 419
25. S.D. Comer, J.B. Ashworth, R.W. Foltin, C.E. Johanson, J.P. Zacny, and S.L. Walsh The role of human drug self-administration procedures in the development of medications Drug Alcohol Depend 96 2008 1 15
26. R.W. Foltin, M. Haney, S.D. Comer, and M.W. Fischman Effects of fenfluramine in food intake, mood, and performance of humans living in a residential laboratory Physiol Behav 59 1996 295 305
27. R.W. Foltin, M.W. Fischman, J.J. Pedroso, and G.D. Pearlson Marijuana and cocaine interactions in humans: Cardiovascular consequences Pharmacol Biochem Behav 28 1987 459 464
28. G.N. Balerio, E. Aso, F. Berrendero, P. Murtra, and R. Maldonado Δ9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice Eur J Neurosci 20 2004 2737 2748
29. B.A. Moore, and A.J. Budney Tobacco smoking in marijuana-dependent outpatients J Substance Abuse 13 2001 583 596
30. R.G. Vandrey, A.J. Budney, J.R. Hughs, and A. Liguori A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances Drug Alcohol Depend 92 2008 48 54
31. M.P. Viveros, E.M. Marco, and S.E. File Nicotine and cannabinoids: Parallels, contrasts and interactions Neurosci Biobehav Rev 30 2006 1161 1181
32. D.M. Penetar, E.M. Kouri, M.M. Gross, E.M. McCarthy, C.K. Rhee, and E.N. Peters Transdermal nicotine alters some of marijuana's effects in male and female volunteers Drug Alcohol Depend 79 2005 211 223
33. G.L. Ream, E. Benoit, B.D. Johnson, and E. Dunlap Smoking tobacco along with marijuana increases symptoms of cannabis dependence Drug Alcohol Depend 95 2008 199 208
34. J.R. Hughes Effects of abstinence from tobacco: Valid symptoms and time course Nicotine Tob Res 9 2007 315 327
35. SRNT Subcommittee on Biochemical Verification Biochemical verification of tobacco use and cessation Nicotine Tob Res 4 2002 149 159
36. Murray A, Levin FL Bisaga A, Glass A, Brooks D. Higher cotinine levels among non-cigarette smoking blunt users versus joint users. In preparation.
37. K.A. Perkins, M. Broge, D. Gerlach, M. Sanders, J.E. Grobe, and C. Cherry Acute nicotine reinforcement, but not chronice tolerance, predicts withdrawal and relapse after quitting smoking Health Psychology 21 2002 332 339
38. M.A. de Dios, E.L. Vaughan, C.A. Stanton, and R. Niaura Adolescent tobacco use and substance abuse treatment outcomes J Subst Abuse Treat 37 2009 17 24
39. D.L. Frosch, S. Shoptaw, D. Nahom, and M.E. Jarvik Associations between tobacco smoking and illicit drug use among methadone-maintained opiate-dependent individuals Exp Clin Psychopharmacol 8 2000 97 103
40. C.S. Kohn, J.Y. Tsoh, and C.M. Weisner Changes in smoking status among substance abusers: Baseline characteristics and abstinence from alcohol and drugs at 12-month follow-up Drug Alcohol Depend 69 2003 61 71
41. S. Shoptaw, M.E. Jarvik, W. Ling, and R.A. Rawson Contingency management for tobacco smoking in methadone-maintained opiate addicts Addict Behav 21 1996 409 412
42. J.J. Prochaska, K. Delucchi, and S.M. Hall A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery J Consult Clin Psychol 72 2004 1144 1156
43. S.B. Gulliver, B.W. Kamholz, and A.W. Helstrom Smoking cessation and alcohol abstinence: What do the data tell us? Alcohol Res Health 29 2006 208 212
44. J. Metrik, N.S. Spillane, A.M. Leventhal, and C.W. Kahler Marijuana use and tobacco smoking cessation among heavy alcohol drinkers Drug Alcohol Depend 119 2011 194 200
45. New York City Department of Health and Mental Hygiene Epi Data Briefs and Tables http://www.nyc.gov/html/doh/html/episrv/epidata.shtml Accessed March 21, 2012
46. J.R. Hughes The hardening hypothesis: Is the ability to quit decreasing due to increasing nicotine dependence? A review and commentary Drug Alcohol Depend 117 2011 111 117
47. W.K. Bickel, A.L. Odum, and G.J. Madden Impulsivity and cigarette smoking: Delay discounting in current, never, and ex-smokers Psychopharmacology 146 1999 447 454
48. J. Dallery, and B.R. Raiff Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement Psychopharmacology 190 2007 485 496
49. K.S. Kendler, J. Myers, and C.A. Prescott Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence Arch Gen Psychiatry 64 2007 1313 1320
50. N.A. Rigotti, J.E. Lee, and H. Wechsler US college students' use of tobacco products: Results of a national survey JAMA 284 2000 699 705
51. M. Mathers, J.W. Toumbourou, R.F. Catalano, J. Williams, and G.C. Patton Consequences of youth tobacco use: A review of prospective behavioral studies Addiction 101 2006 948 958
52. D.E. Ford, H.T. Vu, and J.C. Anthony Marijuana use and cessation of tobacco smoking in adults from a community sample Drug Alcohol Depend 67 2002 243 248
53. SAMHSA (Substance Abuse and Mental Health Services Administration, Office of Applied Studies) Treatment Episode Data Set (TEDS) Highlights - 2007 National Admissions to Substance Abuse Treatment Services OAS Series #S-45, HHS Publication No. (SMA) 09-4360 2009 SAMHSA Rockville, MD
54. A. Levine, Y. Huang, B. Drisaldi, E.A. Griffin Jr, D.D. Pollak, and S. Xu Molecular mechanism for a gateway drug: Epigenetic changes initiated by nicotine prime gene expression by cocaine Sci Transl Med 3 2011 107ra109
55. J.F. Cheer, K.M. Wassum, M.L. Heien, P.E. Phillips, and R.M. Wightman Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats J Neurosci 24 2004 4393 4400
56. P. Fadda, M. Scherma, M.S. Spano, P. Salis, V. Melis, L. Fattore, and W. Fratta Cannabinoid self-administration increases dopamine release in the nucleus accumbens Neuroreport 17 2006 1629 1632
57. G. Tanda, and S.R. Goldberg Cannabinoids: Reward, dependence, and underlying neurochemical mechanisms - a review of recent preclinical data Psychopharmacology (Berl) 169 2003 115 134
58. M.G. Bossong, B.N. van Berckel, R. Boellaard, L. Zuurman, and A.D. Schuit RC Windhorst Delta 9-tetrahydrocannabinol induces dopamine release in the human striatum Neuropsychopharmacology 34 2009 759 766
59. P.R.A. Stokes, M.A. Mehta, H.V. Curran, G. Breen, and P.M. Grasby Can recreational doses of THC produce significant dopamine release in the human striatum? NeuroImage 48 2009 186 190
60. E. Barkus, P.D. Morrison, D. Vuletic, J.C. Dickson, P.J. Ell, and L.S. Pilowsky Does intravenous Δ9-tetrahydrocannabinol increase dopamine release? A SPET study J Psychopharmacol 25 2011 1462 1468
61. R.A. Brown, C.W. Lejuez, D.R. Strong, C.W. Kahler, M.J. Zvolensky, and L.L. Carpenter A prospective examination of distress tolerance and early smoking lapse in adult self-quitters Nicotine Tob Res 11 2009 493 502
62. J.J. Prochaska Failure to treat tobacco use in mental health and addiction treatment settings: A form of harm reduction? Drug Alcohol Depend 110 2010 177 182